The company organizes new employee induction training
Release time:
2020-07-22
Company Organized New Employee Induction Training
News 8# July 5 -7 , more than 30 employees newly recruited by the Company participated in the three-day induction training at the group headquarters, group company chairman Jiang Xiaomeng, general manager Yu Jianhong and other group leaders and heads of relevant enterprises and departments gave lectures for them.
General Manager Yu Jianhong described the development process of the peak from the five stages of hard work, determined reform, diversified development, strategic adjustment and strategic development; introduced the company's industrial layout from the five major sectors of cement, medicine, health, logistics and trade, and other industries; from the enterprise spirit, vision, development concept, values, talent concept, business philosophy, work style and other aspects of the system expounds the profound connotation of the peak enterprise culture. He said that the realization of the centennial goal of the peak still needs the support of more talents. He hopes that the new employees can correctly understand the real economy, persist in continuous learning, grow better and faster, and contribute to the sustainable and healthy development of the peak. Chairman
Jiang Xiaomeng elaborated on the key words 18 that a new peak person needs to understand under the title "How to Grow with the Enterprise. He said that the key to the success of an enterprise lies in selecting, retaining, educating and employing people. Based on his own experience and actual cases, Jiang Xiaomeng analyzed and expounded the success factors in life, the signs of a successful career, and the core elements of his personal career. He hoped that new employees would adjust their mentality in time, study diligently, cultivate the values of honesty and integrity, and be a person with win-win thinking. Establish a personal knowledge management system, make objective self-assessment, clear goals, clear dreams, and formulate a reasonable personal vision, learn to choose and become the talents needed by enterprises.
In order to enable new employees to integrate into the enterprise better and faster, in addition to the lectures given by the chairman and general manager, Tang Zhengren, manager of the human resources department of the group company, explained the enterprise rules and regulations and the employee handbook in detail for the new employees. Li Xiaoyin, director of the group's safety management office, and Jin Huazhong, secretary of the party Committee of the pharmaceutical company, respectively taught safety knowledge and professional ethics.
During the training, the new employees also visited the company's exhibition hall and had a deeper understanding of the entrepreneurial development and corporate culture of the peak. (Reporter Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page